Chiba Y, Iwano H, Tsuneta S, Tsujinaga S, Meyers B, Vlachos P, Ishizaka S, Motoi K, Aoyagi H, Tamaki Y, Tanemura A, Murayama M, Yokoyama S, Nakabachi M, Nishino H, Kaga S, Kamiya K, Ohira H, Tsujino I, Anzai T: “Determinants of altered left ventricular suction in pre-capillary pulmonary hypertension”, Eur Heart J Cardiovasc Imaging, 23(10):1399-1406(2022)
Global Burden of Disease 2019 Adolescent Young Adult Cancer Collaborators: “The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019”, Lancet Oncol, 23(1):27-52(2022)
Global Burden of Disease 2019 Human Resources for Health Collaborators: “Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study2019”, Lancet, 399(10341):2129-2154(2022)
Global Burden of Disease 2019 Cancer Collaboration: “ Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019”, JAMA Oncol ,(3):420-444(2022)
Goudarzi H, Kimura H, Kimura H, Makita H, Matsumoto M, Takei N, Shimizu K, Suzuki M, Watanabe T, Kikuchi E, Ohira H, Tsujino I, Sakakibara-Konishi J, Shinagawa N, Shijubo N, Sato H, Shigehara K, Kaga K, Hida Y, Murakami S, Ebihara Y, Nakamura A, Miyoshi H, Hirano S, Hizawa N, Atsumi T, Huang SK, Ito YM, Nishimura M, Konno S: “Effects of obesity on CC16 and their potential role in overweight/obese asthma”, Respir Res, 23(1):174. doi: 10.1186(2022)
Hata A, Okamoto I, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, Kubota K, Saeki T, Tamura T: “Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE”, J Clin Cocol, ;40(2):180-188(2022)
Hata A, Shiraishi Y, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, Kubota K, Saeki T, Tamura T: “Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)”, Oncol Ther, 10(1):253-262(2022)
Hayashi H, Izumiya Y, Fukuda D, Wakita F, Mizobata Y, Fujii H, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y; CLOT-COVID Study Investigators: “Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan: From the CLOT-COVID Stud”, JACC Asia,2(7):897-907(2022)
Ikari T, Hiratsuka Y, Cheng SY, Miyashita M, Morita T, Mori M, Uneno Y, Amano K, Uehara Y, Yamaguchi T, Maeda I, Inoue A: “Factors associated with good death of patients with advanced cancer: a prospective study in Japan”, Support Care Cancer, 30(11):9577-9586(2022)
Ikeda S, Ueno Y, Maemura K, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y; CLOT-COVID Study Investigators: “Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission - From the CLOT-COVID Study”, Circ J, 87(3):448-455 (2022 )
Ikeda N, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y; CLOT-COVID Study Investigators: “D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan - From the CLOT-COVID Study”, Circ Rep, 4(5):215-221(2022)
Ikezawa Y, Mizugaki H, Morita R, Tateishi K, Yokoo K, Sumi T, Kikuchi H, Kitamura Y, Nakamura A, Kobayashi M, Aso M, Kimura N, Yoshiike F, Furuta M, Tanaka H, Sekikawa M, Hachiya T, Nakamura K, Shimokawa M, Oizumi S: “Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expression”, Cancer Sci,113(6):2109-2117(2022)
Itoh S, Yamazaki K, Suyama S, Ikeda-Araki A, Miyashita C, Ait Bamai Y Kobayashi S, Masuda H, Yamaguchi T, Goudarzi H, Okada E, Kashino I, Saito T, Kishi R: “The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study”, Environ Int, 159:107026(2022)
Kagami K, Ishiguro N, Iwasaki S, Usami T, Fukumoto T, Hayasaka K, Oyamada R, Watanabe T, Nakakubo S, Niinuma Y, “Correlation between antibiotic use and antibiotic resistance: A multicenter study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system in Hokkaido, Japan”, Am J Infect Control, 51:163-171(2022)
Kimura H, Shimizu K, Tanabe N, Makita H, Taniguchi N, Kimura H, Suzuki M, Abe Y, Matsumoto-Sasaki M, Oguma A, Takimoto-Sato M, Takei N, Matsumoto M, Goudarzi H, Sato S, Ono J, Izuhara K, Hirai T, Nishimura M, Konno S: “Further evidence for association of YKL-40 with severe asthma airway remodeling”, Ann Allergy Asthma Immunol, 128(6):682-688(2022)
Kobayashi S, Sata F, Ikeda-Araki A, Miyashita C, Goudarzi H, Iwasaki Y, Nakajima T, Kishi R: “Relationships between maternal perfluoroalkyl substance levels, polymorphisms of receptor genes, and adverse birth outcomes in the Hokkaido birth cohort study, Japan”, Reprod Toxicol, 107:112-122(2022)
Kobayashi S, Sata F, Miyashita C, Ikeda-Araki A, Goudarzi H, Nakajima T, Kishi R: “Associations between maternal mono-(2-ethylhexyl) phthalate levels, nuclear receptor gene polymorphisms, and fatty acid levels in pregnant Japanese women in the Hokkaido study”, Reprod Toxicol, 107:22-32(2022)
Kojima Y, Nakakubo S, Kamada K, Yamashita Y, Takei N, Nakamura J, Matsumoto M, Horii H, Sato K, Shima H, Suzuki M, Konno S: “ Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study”, J Med Virol, 94(12):5702-5712(2022)
Kojima Y, Nakakubo S, Takei N, Kamada K, Yamashita Y, Nakamura J, Matsumoto M, Horii H, Sato K, Shima H, Suzuki M, Konno S: “ Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study”, Medicina (Kaunas, Lithuania), 58 (4):513(2022)
Kuroki A, Takamura K, Sasaki M, Kikichi H, Yamamoto M: “Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults”, J Rural Med, 17(1):29-32(2022)
Masuda S, Kato K, Ishibashi M, Nishibata Y, Sugimoto A, Nakazawa D, Tanaka S, Tomaru U, Tsujino I, Ishizu A: “Phorbol 12-myristate 13-acetate stimulation under hypoxia induces nuclear swelling with DNA outflow but not extracellular trap formation of neutrophils”, Exp Mol Pathol, 125:104754(2022)
Matsumoto-Sasaki M, Shimizu K, Suzuki M, Suzuki M, Kimura H, Nakamaru Y, Ito YM, Honma A, Konno S: “Clinical characteristics of patients and factors associated with switching biologics in asthma”, J Asthma Allergy,15:187-195(2022)
Matsumoto-Sasaki M, Suzuki M, Kimura H, Shimizu K, Makita H, Nishimura M, Konno S: “Association of longitudinal changes in quality of life with comorbidities and exacerbations in patients with severe asthma”, Allergol Int,71(4):481-489(2022)
Mizugaki H, Oizumi S, Fujita Y, Harada T, Nakahara Y, Takashina T, Ko R, Watanabe K, Hotta T, Minemura H, Saeki S, Asahina H, Nakamura H, Hosoda F, Yagishita S, Nakamura K, Hamada A: “Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer”, Eur J Cancer, 160:227-234(2022)
Mochizuki F, Tanabe N, Iijima H, Shimada T, Maetani T, Yamazaki H, Shimizu K, Suzuki M, Chubachi S, Ishikawa H, Naito T, Masuko H, Sakamoto T, Masuda I, Sato S, Hizawa N, Hirai T: “Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features”, Respir Med, 204:107011(2022)
Nakamura J, Tsujino I, Ohira H, Nakaya T, Sugimoto A, Sato T, Watanabe T, Suzuki M, Kato M, Yokota I, Konno S: “Various factors contribute to death in patients with different types of pulmonary hypertension: A retrospective pilot study from a single tertiary center”, Respir Investig, 60(5):647-657(2022)
Nakamura J, Tsujino I, Shima H, Nakaya T, Sugimoto A, Sato T, Watanabe T, Ohira H, Suzuki M, Tsuneta S, Hisada R, Kato M, Konno S: “Efficacy and safety of oral pulmonary vasodilators in pulmonary veno-occlusive disease”, Pulm Circ,12(4): e12168(2022)
Nakamura J, Tsujino I, Yachi S, Takeyama M, Nishimoto Y, Konno S, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y, on behalf of the CLOT-COVID Study Investigators: “Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study”, Thromb J, 20(1):53. doi: 10.1186（2022）
Nishimoto Y, Yachi S, Takeyama M, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y; CLOT-COVID Study Investigators: “The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study”, J Cardiol, 80(4):285-291(2022)
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group: “Selexipag for the treatment of chronic thromboembolic pulmonary hypertension”, Eur Respir J, 60(1):2101694(2022)
Ohira H, deKemp R, Kadoya Y, Renaud J, Stewart DJ, Davies RA, Chandy G, Contreras-Dominguez V, Pugliese C, Dunne R, Beanlands R, Mielniczuk L: “Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease”, Ann Nucl Cardiol, 8(1):21-29(2022)
Ohira H, Sato T, Manabe O, Oyama-Manabe N, Hayashishita A, Nakaya T, Nakamura J, Suzuki N, Sugimoto A, Furuya S, Tsuneta S, Watanabe T, Tsujino I, Konno S: “Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis”, ERJ Open Res, 8(2):00516-2021(2022)
Saito Y, Sakamoto T, Takekuma Y, Kobayashi M, Okamoto K, Shinagawa N, Shimizu Y, Kinoshita I, Sugawara M: “Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis”, Sci Rep, 12(1):21819(2022)
Saito Y, Takekuma Y, Kobayashi M, Shinagawa N, Noguchi T, Takeuchi S , Shimizu Y, Kinoshita I, Dosaka-Akita H, Sugawara M : “Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method”, Anticancer Res, 42(6): 3185-3193(2022)
Saito Y, Takekuma Y, Shinagawa N, Sugawara M: “Evaluation of risk factors associated with carboplatin and nab-paclitaxel treatment suspension in patients with non-small cell lung cancer”, Support Care Cancer , 30(5):4081-4088(2022)
Seyama K, Suzuki M, Tasaka S, Nukiwa T, Sato T, Konno S, Sorrells S, Chen J, Aragonés ME, Minamino H: “Long-term safety of Prolastin®-C, an alpha1-proteinase inhibitor, in Japanese patients with alpha1-antitrypsin deficiency”, Respir Investig, 60(6):831-839(2022)
Shima H, Nakaya T, Tsujino I, Nakamura J, Sugimoto A, Sato T, Watanabe T, Ohira H, Suzuki M, Kato M, Yokota I, Konno S: “Accuracy of Swan‒Ganz catheterization-based assessment of right ventricular function: Validation study using high-fidelity micromanometry-derived values as reference”, Pulm Circ, 12(2): e12078(2022)
Shimizu K, Tanabe N, Oguma A, Kimura H, Suzuki M, Yokota I, Makita H, Sato S, Hirai T, Nishimura M, Konno S: “Parenchymal destruction in asthma: Fixed airflow obstruction and lung function trajectory”, J Allergy Clin Immunol, 149(3):934-942(2022)
Takada K, Kubo T, Kikuchi J, Yoshida M, Murota A, Arihara Y, Nakamura H, Nagashima H, Tanabe H, Sugita S, Tanaka Y, Miura A, Ohhara Y, Ishiguro A, Yokouchi H, Kawamoto Y, Mizukami Y, Ohnishi H, Kinoshita I, Sakurai A: “Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study”, Front Oncol, 12:988527(2022)
Takashima Y, Shinagawa N, Morinaga D, Nakamura J, Furuta M, Shoji T, Asahina H, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Tsujino I, Konno S: “Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary hypertension”, BMC Pulm Med, 22(1):449(2022)
Tamura Y, Kumamaru H, Inami T, Matsubara H, Hirata KI, Tsujino I, Suda R, Miyata H, Nishimura S, Sigel B, Takano M, Tatsumi K; Japan Pulmonary Hypertension Registry (JAPHR) Network: “Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan”, JACC Asia,2(3):273-284(2022)
Tamura Y, Tamura Y, Taniguchi Y, Tsujino I, Inami T, Matsubara H, Shigeta A, Sugiyama Y, Adachi S, Abe K, Baba Y, Hatano M, Ikeda S, Kusunose K, Sugimura K, Usui S, Takeishi Y, Dohi K, Hasegawa-Tamba S, Horimoto K, Kikuchi N, Kumamaru H, Tatsumi K; Japan Pulmonary Hypertension Registry Network: “Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry”, Circ Rep, 4(11):542-549(2022)
Taniguchi H, Caeser R, Chavan SS, Zhan YA, Chow A, Manoj P, Uddin F, Kitai H, Qu R, Hayatt O, Shah NS, Quintanal Villalonga Á, Allaj V, Nguyen EM, Chan J, Michel AO, Mukae H, de Stanchina E, Rudin CM, Sen T: “WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC”, Cell report, 39(7):110814(2022)
Yamamoto R, Asano H, Umazume T, Takaoka M, Noshiro K, Saito Y, Nakagawa K, Chiba K, Nakakubo S, Nasuhara Y, Konno S, Watari H: “C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study”, J Obstet Gynaecol Res,48(4):938-945(2022)
Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M: “Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational Study”, Circ J, 86(7):1137-1142(2022)
Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M; CLOT-COVID Study Investigators: “Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study”, Thromb Res, 213:173-178(2022)
Hatakeyama Y, Nakakubo S, Kusaka H, Watanabe N, Yoshida Y, Shinzaki H, Hiroumi H, Kishida N, Konno S: “Listeria monocytogenes bacteremia mimicking the systemic metastasis of adrenal cancer: a case report”, BMC Infect Dis, 22(1):789 (2022)
Kojima Y, Takeyabu K, Satoh M, Konno S: “Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report”, Clin Infect Pract, 16:100204(2022).
Matsumoto-Sasaki M, Shimizu K, Suzuki M, Suzuki M, Kimura H, Nakamaru Y, Ito YM, Honma A, Konno S: “Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma”, J Asthma Allergy, 15:187-195(2022)
Takahashi Y, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Nishimura H, Kimura H, Suzuki M, Konno S, Shimizu A,Okamoto Y, Motegi H, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Miyoshi H, Atsumi T: “Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis”, Pituitary, 252(2):321-327(2022)
Takimoto-Sato M, Miyauchi T, Suzuki M, Ujiie H, Nomura T, Ikari T, Nakamura T, Takahashi K, Matsumoto-Sasaki M, Kimura H, Kimura H, Matsui Y, Kitagataya T, Yamada R, Suzuki K, Nakamura A, Nakai M, Sho T, Ogawa K, Sakamoto N, Yamaguchi N, Otsuka N, Tomaru U, Konno S: “Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia”, Front Genet, 13:870192(2022)
Yamamoto G, Takamura K, Ishida Y, Sato Y, Sinozaki A, Kikuchi H, Yamamoto M, Kobayashi H, Hirose N, Kikuchi K: “Use of broncholveolar lavage in diagnosing angioimmunoblastic T-cell lymphoma: A case report”, Respirology Case Reports, 3;10(4):e0924(2022).
Wakazono N, Mizushima A, Maeda Y, Taniguchi N, Nagai K, Hattori A, Harada T: “A 60-Year-Old Woman With Posterior Mediastinal Tumor”, Chest, 162(2):e81-e84(2022)
鈴木孝敏，長井 桂，若園順康，水島亜玲，前田由起子，谷口菜津子，原田敏之： “Acute eosinophilic pneumonia caused by composter vapor inhalation: A case report”，Respir Investig, 60(6):857-860(2022)
総説・解説・その他Reviews, Commentaries & Other Publications
Goudarzi H, Kimura H, Makita H, Abe Y, Oguma A, Sato M, Matsumoto M, Takei N, Kimura H, Shimizu K, Suzuki M, Ito YM, Nishimura M, Konno S, HiCARAT investigators: “Association of abdominal visceral adiposity with sputum IL-5 levels in asthma”, Allergol Int,71(1):137-139(2022)
Kamada K, Mitarai S: “Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem?”, Antibiotics, 11(1):19. doi: 10.3390(2022)
Nakakubo S, Kamada K, Yamashita Y, Nakamura J, Matsumoto M, Horii H, Sato K, Morinaga D, Suzuki M, Okazaki N, Takakuwa E, Matsuno Y, Konno S: “Delayed-onset organizing pneumonia emerging after recovery from coronavirus disease 2019: A report of three cases diagnosed using transbronchial cryobiopsy and a review of the literature”, Intern Med,61(9):1403-1410(2022)
Tanabe N, Rhee CK, Park HY, Suzuki M: “Editorial: The heterogeneity in COPD phenotypes”, Front Med (Lausanne), 9:982121(2022)
